SABRATEK CORP (SBTK) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SABRATEK CORP (SBTK)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Madpinto who wrote (23)	7/13/1998 10:57:00 PM
From: Mike	Read Replies (1) of 487

Does anyone have any information as to how the two contracts will help or hurt earnings? The two contracts awarded over the past couple weeks have been from Premier and Omnicare. The Omnicare contract was a "prime vendor" contract. Both contract are on SBTK's Reocap Flush product line. The reason why I say "hurt" earnings is due to the potential low margins on this product. There is no question that these contracts have the potential to help sales as long as they are executed right. Can anyone comment on the margins this product has for SBTK. The market may see this lower margin sales as the beginning of the end. So if anyone can make comments it would be greatly appreciated. In addition, can SBTK be a high volume profitable manufacturer? Comments appreciated, Mike

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next